DAYBREAK: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04963231 |
|
Recruitment Status :
Recruiting
First Posted : July 15, 2021
Last Update Posted : November 30, 2022
|
Sponsor:
Rhythm Pharmaceuticals, Inc.
Information provided by (Responsible Party):
Rhythm Pharmaceuticals, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | October 2024 |
| Estimated Study Completion Date : | October 2024 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):